Number of the records: 1  

Study of the production yields of .sup.18./sup.F, .sup.11./sup.C, .sup.13./sup.N and .sup.15./sup.O positron emitters from plasma-laser proton sources at ELI-Beamlines for labeling of PET radiopharmaceuticals

  1. 1.
    0488129 - FZÚ 2018 RIV NL eng J - Journal Article
    Amato, E. - Italiano, A. - Margarone, Daniele - Pagano, B. - Baldari, S. - Korn, Georg
    Study of the production yields of 18F, 11C, 13N and 15O positron emitters from plasma-laser proton sources at ELI-Beamlines for labeling of PET radiopharmaceuticals.
    Nuclear Instruments & Methods in Physics Research Section A. Roč. 811, Mar (2016), s. 1-5. ISSN 0168-9002. E-ISSN 1872-9576
    R&D Projects: GA MŠMT ED1.1.00/02.0061; GA MŠMT EF15_008/0000162
    Grant - others:ELI Beamlines(XE) CZ.1.05/1.1.00/02.0061; ELI Beamlines(XE) CZ.02.1.01/0.0/0.0/15_008/0000162
    Institutional support: RVO:68378271
    Keywords : plasma laser * proton acceleration * positron emission tomography * microfluidics
    OECD category: Fluids and plasma physics (including surface physics)
    Impact factor: 1.362, year: 2016

    The development of novel compact PET radionuclide production systems is of great interest to promote the diffusion of PET diagnostics, especially in view of the continuous development of microfluidics labeling approaches. We studied the feasibility to produce clinically-relevant amounts of PET isotopes by means of laser-accelerated proton sources such that expected at the ELI-Beamlines facility. F-18, C-11, N-13 and O-15 production yields were calculated through the TALYS software, by taking into account the broad proton spectra expected. With the hypothesized proton fluencies, clinically-relevant amounts of radionuclides can be obtained, suitable to prepare single doses of F-18-, C-11- and N-13-labeled radio pharmaceuticals exploiting fast and efficient microfluidic labeling systems.
    Permanent Link: http://hdl.handle.net/11104/0282748

     
     
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.